ABN Newswire is a business newswire and press release distribution service for listed companies on stock exchanges globally. ABN Newswire distributes company announcements to the professional platforms, finance portals and syndicates important corporate news to a wide variety of news aggregators and financial news systems.
Biotec Pharmacon ASA (OSL:BIOTEC) Biotec Pharmacon ASA has entered into a new market making agreement for the company`s shares. The agreement is entered into with DnB NOR Markets who undertakes to quote bid- and offer prices in the share for at least 4 round lots and with a maximum spread of 4%. The agreement is based on Oslo Børs` requirements for liquidity provider agreements, and will become effective starting from January 26th, 2009. The agreement replaces the previous market maker agreement with SEB Enskilda.
This announcement was originally distributed by Hugin. The issuer is solely responsible for the content of this announcement.